Islamic Finance Market Size and Share | Mordor Intelligence Mordor Intelligence has published a new report on the Islamic finance market, offering a comprehensive analysis of trends, growth drivers, and
Immersion Cooling Fluids Market The latest research by Mordor Intelligence covers the “Immersion Cooling Fluids” delivering insights into market dynamics, drivers of growth, and long-term forecasts. Hyderabad, India, October 09,
The market dynamics for Cutaneous Lupus Erythematosus (CLE) are witnessing significant growth, driven by increasing disease awareness, improvements in diagnosis, persistent unmet medical needs, and advancements in targeted immunotherapies. The
The market dynamics for Epstein-Barr virus (EBV) are evolving, driven by the high prevalence of infection worldwide, the growing recognition of EBV-associated malignancies and other complications, and the need for
The market dynamics for osteoarthritis are witnessing steady growth, driven by the rising disease burden associated with aging populations, increasing obesity rates, and the growing need for effective long-term pain
(Albany, New York) – October 09, 2026: DelveInsight’s “Bulimia Nervosa Market Insights, Epidemiology, and Market Forecast – 2036” report delivers an in-depth understanding of bulimia nervosa, covering historical and forecasted epidemiology,
(Albany, New York) – October 09, 2026: DelveInsight’s “Bone Metastasis in Solid Tumor Market Insights, Epidemiology, and Market Forecast 2036” report provides a comprehensive analysis of bone metastasis in solid tumors,
The Key IgA Nephropathy Companies in the market include – Travere Therapeutics, Asahi Kasei (Calliditas Therapeutics), Vertex Pharmaceuticals, Vera Therapeutics, Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences, Shanghai Alebund
(Albany, New York) – October 09, 2026: As per DelveInsight’s assessment, globally, Mantle Cell Lymphoma pipeline constitutes 20+ key companies continuously working towards developing 25+ Mantle Cell Lymphoma treatment therapies,
(Albany, New York) – October 09, 2026: As per DelveInsight’s assessment, globally, HER2-Positive Breast Cancer pipeline constitutes 50+ key companies continuously working towards developing 55+ HER2-Positive Breast Cancer treatment therapies,
